Using Real World Data for a Successful Commercialization Strategy
Oncology – perhaps more than any other therapeutic area – has undergone significant disruption and transformation due to advances in standards of care, use of combination therapies, precision medicine innovations, and reimbursement changes. Successful commercialization strategies are dependent upon detailed market insights and data analytics utilizing real- world data. Manufacturers require timely and complete insights to inform these brand and commercial strategies, including monitoring market share by line of therapy by indication, measuring duration of therapy by line of therapy by drug or drug combination, and more.
Pooja Chopra
Manager in Consulting Analytics and Strategy
McKesson Life Sciences
Michelle Meyers
Senior Director, Data, Evidence, & Insights
McKesson Life Sciences
In this webinar, McKesson Life Sciences will present case studies showcasing how biopharma commercialization strategies were developed using the McKesson integrated, patient-linked real-world, retrospective and prospective database representing the community oncology market. Examples of how these data can provide a holistic view across the entire patient journey in real-time will be shown.
The webinar will appeal to commercialization team including brand and market access teams as well as anyone who is interested in oncology data and will provide key learnings in the following areas:
- Identify the different sources of real world data and how it can support your commercial needs
- Learn about the opportunities to use real data to deploy targeted commercial strategies
- Understand how to differentiate your product in the market place through the use of data
